Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Pérez Álvarez, Maria J ^a,b   Maza, Maria del C ^a,b   Anton, Marta ^a,b   Ordoñez, Lara ^a,b   Wandosell, Francisco ^a,b,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c CSIC   (Spain)

Author keywords

Akt; Brain; Estradiol; Estrogen; Focal ischemia; Immunohistochemistry; MCAO; Neuroprotection; Rat; Stroke; Western blot

Indexed keywords

BETA CATENIN; CELL MARKER; ESTRADIOL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOGEN SYNTHASE KINASE 3; IBA1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLIA CELL; GLIOSIS; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 84864809822     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-157     Document Type: Article

References (77)

1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, . American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2007, 115:e69-e171. 10.1161/CIRCULATIONAHA.106.179918, 17194875, American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
2. Céspedes-Rubio A, Jurado FW, Cardona-Gómez GP. p120 catenin/αN-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia. J Neurosci Res 2010, 88:3621-3634. 10.1002/jnr.22511, 20936696.
3. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397. 10.1016/S0166-2236(99)01401-0, 10441299.
4. Richard Green A, Odergren T, Ashwood T. Animal models of stroke: do they have value for discovering neuroprotective agents?. Trends Pharmacol Sci 2003, 24:402-408. 10.1016/S0165-6147(03)00192-5, 12915049.
5. Hossmann K-A. Pathophysiology and therapy of experimental stroke. Cel Mol Neurobiol 2006, 26:1055-1081.
6. Block F, Dihné M, Loos M. Inflammation in areas of remote changes following focal brain lesion. Prog Neurobiol 2005, 75:342-365. 10.1016/j.pneurobio.2005.03.004, 15925027.
7. Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM. Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications. Steroids 2007, 72:381-405. 10.1016/j.steroids.2007.02.003, 2048656, 17379265.
8. Lang J, McCullough L. Pathways to ischemic neuronal cell death:are sex differences relevant?. J Transl Med 2008, 223:6-33.
9. Bushnell C. Stroke and the female brain. Nat Clin Pract Neurol 2008, 4:22-33.
10. Hoffman GE MI, Zup SL. Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 2006, 29:14.
11. Alkayed N, Harukuni I, Kimes A, London E, Traystman R, Hurn P. Gender-linked brain injury in experimental stroke. Stroke 1998, 29:159-165. 10.1161/01.STR.29.1.159, 9445346.
12. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998, 18:1253-1258.
13. Toung TJK, Traystman RJ, Hurn PD. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 1998, 29:1666-1670. 1666-1670, 10.1161/01.STR.29.8.1666, 9707210.
14. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 1999, 19:6385-6393.
15. Dubal DB, Wise PM. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001, 142:43-48. 10.1210/en.142.1.43, 11145565.
16. Won CK, Ji HH, Koh PO. Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci Lett 2006, 398:39-43. 10.1016/j.neulet.2005.12.060, 16423457.
17. McCullough L, Hurn P. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrin Metab 2003, 14:228-235.
18. Koh PO. Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation. Neurosci Lett 2007, 412:68-72. 10.1016/j.neulet.2006.10.060, 17196335.
19. Koh PO, Won CK, Cho JH. Estradiol prevents the injury-induced decrease of Akt/glycogen synthase kinase 3[beta] phosphorylation. Neurosci Lett 2006, 404:303-308. 10.1016/j.neulet.2006.06.020, 16815634.
20. Yang S-H, Shi J, Day AL, Simpkins JW. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 2000, 31:745-750. 10.1161/01.STR.31.3.745, 10700514.
21. Bingham D, Macrae IM, Carswell HV. Detrimental effects of 17[beta]-oestradiol after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 2005, 25:414-420. 10.1038/sj.jcbfm.9600031, 15647739.
22. Farr TD, Carswell HVO, Gallagher L, Condon B, Fagan AJ, Mullin J, Macrae IM. 17[beta]-Estradiol treatment following permanent focal ischemia does not influence recovery of sensorimotor function. Neurobiol Dis 2006, 23:552-562. 10.1016/j.nbd.2006.04.009, 16759876.
23. Cardona-Gómez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Rev 2001, 37:320-334. 10.1016/S0165-0173(01)00137-0, 11744097.
24. Mendez P, Azcoitia I, Garcia-Segura LM. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Mol Brain Res 2003, 112:170-176. 10.1016/S0169-328X(03)00088-3, 12670715.
25. Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K, Goddard S, Gobert-Gosse S, Corbo L. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 2008, 31:212-221. 10.1016/j.molcel.2008.05.025, 18657504.
26. Varea O, Garrido JJ, Dopazo A, Mendez P, Garcia-Segura LM, Wandosell F. Estradiol activates beta-Catenin dependent transcription in neurons. PLoS ONE 2009, 4:e5153. 10.1371/journal.pone.0005153, 2664482, 19360103.
27. Garcia-Segura LM, Diz-Chaves Y, Perez-Martin M, Darnaudéry M. Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology 2007, 32:S57-S61.
28. Endo H, Nito C, Kamada H, Nishi T, Chan PH. Activation of the Akt//GSK3[beta] signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab 2006, 26:1479-1489. 10.1038/sj.jcbfm.9600303, 16538228.
29. Sun B, Chen L, Wei X, Xiang Y, Liu X, Zhang X. The Akt/GSK-3[beta] pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rats. Biochem Biophys Res Comm 2011, 409:808-813. 10.1016/j.bbrc.2011.05.095, 21624354.
30. Noshita N, Lewen A, Sugawara T, Chan PH. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2001, 21:1442-1450.
31. Rau TF, Kothiwal A, Zhang L, Ulatowski S, Jacobson S, Brooks DM, Cardozo-Pelaez F, Chopp M, Poulsen DJ. Low dose methamphetamine mediates neuroprotection through a PI3K-AKT pathway. Neuropharmacology 2011, 61:677-686. 10.1016/j.neuropharm.2011.05.010, 21635908.
32. Nozaki K, Nishimura M, Hashimoto N. Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol 2001, 23:1-19. 10.1385/MN:23:1:01, 11642541.
33. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993, 268:14553-14556.
34. Verheij M, Bose R, Hua Lin X, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996, 380:75-79. 10.1038/380075a0, 8598911.
35. Wu D-C, Ye W, Che X-M, Yang G-Y. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab 2000, 20:1320-1330. 10.1097/00004647-200009000-00007, 10994854.
36. Irving EA, Barone FC, Reith AD, Hadingham SJ, Parsons AA. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Mol Brain Res 2000, 77:65-75. 10.1016/S0169-328X(00)00043-7, 10814833.
37. Shioda S, Ozawa H, Dohi K, Mizushima H, Matsumoto K, Nakajo S, Takaki A, Zhou CJ, Nakai Y, Arimura A. PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway. Ann N Y Acad Sci 1998, 865:111-117. 10.1111/j.1749-6632.1998.tb11169.x, 9928003.
38. Lennmyr F, Karlsson S, Gerwins P, Ata KA, Terént A. Activation of mitogen-activated protein kinases in experimental cerebral ischemia. Acta Neurol Scand 2002, 106:333-340. 10.1034/j.1600-0404.2002.01313.x, 12460137.
39. Benakis C, Bonny C, Hirt L. JNK inhibition and inflammation after cerebral ischemia. Brain Behav Immun 2010, 24:800-811. 10.1016/j.bbi.2009.11.001, 19903520.
40. Shimoke K, Yamagishi S, Yamada M, Ikeuchi T, Hatanaka H. Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons. Brain Res Dev Brain Res 1999, 112:245-253.
41. Longa EZWP, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:8.
42. Yrjänheikki J, Koistinaho J, Kettunen M, Kauppinen RA, Appel K, Hüll M, Fiebich BL. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res 2005, 1052:174-179. 10.1016/j.brainres.2005.06.004, 16023089.
43. Paxinos G, Watson C. The rat brain in stereotaxic coordinates 2007, Academic, San Diego, CA, 6.
44. Araujo M, Wandosell F. Differential cellular response after glutamate analog hippocampal damage. J Neurosci Res 1996, 44:397-409. 10.1002/(SICI)1097-4547(19960515)44:4<397::AID-JNR11>3.0.CO;2-#, 8739159.
45. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A, Shimohama S. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 2000, 60:321-327. 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.0.CO;2-T, 10797534.
46. Mines MA, Beurel E, Jope RS. Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3. International Journal of Alzheimer's Disease 2011, 2011:861072.
47. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Ann Rev Cell Dev Biol 2004, 20:781-810.
48. Liu F, McCullough LD. Middle cerebral artery occlusion model in rodents: methods and potential fitfalls. J Biomed Biotechnol 2011, 2011:464701. 3035178, 21331357.
49. Koh P-O, Cho J-H, Won C-K, Lee H-J, Sung J-H, Kim M-O. Estradiol attenuates the focal cerebral ischemic injury through mTOR/p70S6 kinase signaling pathway. Neurosci Lett 2008, 436:62-66. 10.1016/j.neulet.2008.02.061, 18378082.
50. Kriz J. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol 2006, 18(1-2):145-157. 10.1615/CritRevNeurobiol.v18.i1-2.150, 17725517.
51. Bovolenta P, Wandosell F, Nieto-Sampedro M. CNS glial scar tissue: a source of molecules which inhibit central neurite outgrowth. Prog Brain Res 1992, 94:367-379.
52. Bovolenta P, Wandosell F, Nieto-Sampedro M. Characterization of a neurite outgrowth inhibitor expressed after CNS injury. Eur J Neurosci 1993, 5:454-465. 10.1111/j.1460-9568.1993.tb00512.x, 8261122.
53. Mingorance A, Fontana X, Sole M, Burgaya F, Urena JM, Teng FY, Tang BL, Hunt D, Anderson PN, Bethea JR, Schwab ME, Soriano E, del Rio JA. Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol Cell Neurosci 2004, 26:34-49. 10.1016/j.mcn.2004.01.001, 15121177.
54. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo J, Zhang W, So KF, Pepinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007, 13:1228-1233. 10.1038/nm1664, 17906634.
55. Nash M, Pribiag H, Fournier AE, Jacobson C. Central nervous system regeneration inhibitors and their intracellular substrates. Mol Neurobiol 2009, 40:224-235. 10.1007/s12035-009-8083-y, 19763907.
56. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007, 184:53-68. 10.1016/j.jneuroim.2006.11.014, 1868538, 17188755.
57. Arevalo MA, Diz-Chaves Y, Santos-Galindo M, Bellini MJ, Garcia-Segura LM. Selective Oestrogen receptor modulators decrease the inflammatory response of glial cells. J Neuroendocrinol 2012, 24:183-190. 10.1111/j.1365-2826.2011.02156.x, 21564348.
58. Barreto G, Santos-Galindo M, Diz-Chaves Y, Pernia O, Carrero P, Azcoitia I, Garcia-Segura LM. Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones. Endocrinology 2009, 150:5010-5015. 10.1210/en.2009-0352, 19797123.
59. Ritz MF, Hausmann ON. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res 2008, 1203:177-188.
60. Lewis DK, Johnson AB, Stohlgren S, Harms A, Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J Neuroimmunol 2008, 195:47-59. 10.1016/j.jneuroim.2008.01.006, 2394738, 18328572.
61. Sarvari M, Hrabovszky E, Kallo I, Solymosi N, Toth K, Liko I, Szeles J, Maho S, Molnar B, Liposits Z. Estrogens regulate neuroinflammatory genes via estrogen receptors alpha and beta in the frontal cortex of middle-aged female rats. J Neuroinflammation 2011, 8:82. 10.1186/1742-2094-8-82, 3161870, 21774811.
62. Zhou X, Zhou J, Li X. Guo Ca, Fang T, Chen Z: GSK-3[beta] inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury. Biochem Biophys Res Commun 2011, 411:271-275. 10.1016/j.bbrc.2011.06.117, 21723251.
63. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy from molecular mechanisms to therapeutic benefits. Biochimica et Biophysica Acta (BBA) 2005, 1754:253-262.
64. Choi DW. Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 1996, 6:667-672. 10.1016/S0959-4388(96)80101-2, 8937832.
65. Li Y, Chopp M, Powers C, Jiang N. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Res 1997, 765:301-312. 10.1016/S0006-8993(97)00524-6, 9313903.
66. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 1998, 273:19929-19932. 10.1074/jbc.273.32.19929, 9685326.
67. Amantea D, Fratto V, Maida S, Rotiroti D, Ragusa S, Nappi G, Bagetta G, Corasaniti MT, Bagetta G. Prevention of glutamate accumulation and upregulation of phospho-Akt may account for neuroprotection afforded by bergamot essential oil against brain injury induced by focal cerebral ischemia in rat. Int Rev Neurobiol 2009, 85:389-405.
68. Shibata M, Yamawaki T, Sasaki T, Hattori H, Hamada J, Fukuuchi Y, Okano H, Miura M. Upregulation of Akt phosphorylation at the early stage of middle cerebral artery occlusion in mice. Brain Res 2002, 942:1-10. 10.1016/S0006-8993(02)02474-5, 12031847.
69. Kitagawa H, Warita H, Sasaki C, Ri Zhang W, Sakai K, Shiro Y, Mitsumoto Y, Mori T, Abe K. Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain. Neurosci Lett 1999, 274:45-48. 10.1016/S0304-3940(99)00676-X, 10530516.
70. Franke TF, Yang S-I, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81:727-736. 10.1016/0092-8674(95)90534-0, 7774014.
71. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex. Science 2005, 307:1098-1101. 10.1126/science.1106148, 15718470.
72. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006, 127:125-137. 10.1016/j.cell.2006.08.033, 16962653.
73. Hwang SK, Kim HH. The functions of mTOR in ischemic diseases. BMB Rep 2011, 44:506-511. 10.5483/BMBRep.2011.44.8.506, 21871173.
74. Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM, Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol Cell Neurosci 2004, 25:363-373. 10.1016/j.mcn.2003.10.008, 15033165.
75. Read D, Gorman A. Involvement of Akt in neurite outgrowth. Cell Mol Life Sci 2009, 66:2975-2984. 10.1007/s00018-009-0057-8, 19504044.
76. Liu C, Wu J, Xu K, Cai F, Gu J, Ma L, Chen J. Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. J Neurochemistry 2010, 112:1500-1512.
77. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 2001, 20:27-39. 10.1093/emboj/20.1.27, 140191, 11226152.